Citations 0
March 3, 2004

Management of Cancer Pain

Author Affiliations

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(9):1067-1068. doi:10.1001/jama.291.9.1068-b

To the Editor: Drs Bruera and Kim1 did not discuss the risk of opioid-induced respiratory depression, which is one of the primary fears that inhibit many physicians from adequately treating cancer pain with these medications. The perceived risk of initiating respiratory collapse and accelerating death with opioid medications is often overestimated and exaggerated among physicians.2

First Page Preview View Large
First page PDF preview
First page PDF preview